ASX:COH Cochlear (COH) Stock Price, News & Analysis → Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (From GoldenCrest Metals) (Ad) Free COH Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume201,277 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.19%Price TargetN/A Stock AnalysisStock Analysis Get Cochlear alerts: Email Address Ad GoldenCrest MetalsExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsBig Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.Learn More Now About Cochlear Stock (ASX:COH)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More Ad GoldenCrest MetalsExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsBig Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.Learn More Now COH Stock News HeadlinesApril 19, 2024 | finance.yahoo.comCochlear receives FDA clearance to lower the age for the Osia System to 5-years-oldApril 2, 2024 | fxstreet.comCochlear Limited Elliott Wave technical forecast [Video]April 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.March 25, 2024 | finance.yahoo.comInvesting in Cochlear (ASX:COH) five years ago would have delivered you a 104% gainMarch 21, 2024 | markets.businessinsider.comCochlear Limited (CHEOF) Gets a Sell from Morgan StanleyMarch 8, 2024 | finance.yahoo.comShould You Be Adding Cochlear (ASX:COH) To Your Watchlist Today?February 19, 2024 | markets.businessinsider.comHere’s Why Cochlear (COH) Shares Fell Despite Robust ProfitsFebruary 19, 2024 | msn.comASX Large Caps: Property stocks smashed after Lendlease-led rout, a2 Milk soars on solid guidanceApril 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.February 18, 2024 | msn.comASX 200 opens 0.1% higher; Westpac, Cochlear, Ampol report earningsFebruary 11, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Cochlear Limited (OtherCHEOF) and Demant (OtherWILLF)February 8, 2024 | markets.businessinsider.comHere’s Why Cochlear (COH) Shares Rose TodayFebruary 7, 2024 | msn.comASX Health Stocks: Cochlear upgrades guidance, Chimeric up 12pc after commencing Phase 1B trial on leukaemiaFebruary 7, 2024 | msn.comClosing Bell: Interest rates the only thing steady about local markets on TuesdayFebruary 5, 2024 | fool.com.auWhy is the Cochlear share price tumbling 5% on Tuesday?January 24, 2024 | finance.yahoo.comCochlear and TechSee Win Silver in the 13th Annual Best in Biz Awards 2023January 21, 2024 | sg.finance.yahoo.comCochlear Ltd (OC5.SG)December 17, 2023 | finance.yahoo.comUnpleasant Surprises Could Be In Store For Cochlear Limited's (ASX:COH) SharesDecember 13, 2023 | morningstar.comCurro Holdings Ltd COHNovember 25, 2023 | finance.yahoo.comIs Cochlear Limited's (ASX:COH) Recent Stock Performance Tethered To Its Strong Fundamentals?November 15, 2023 | fool.com.auAnalysts say these world-class ASX 200 blue chip shares are buysNovember 15, 2023 | morningstar.comCochlear Ltd COHNovember 10, 2023 | finanznachrichten.deEnvoy Medical, Inc: Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear SystemsOctober 31, 2023 | fool.com.auBuy and hold this ASX 200 share which is a long term market leader: brokerOctober 24, 2023 | forbes.comCochlear Implants vs. Hearing Aids: What’s The Difference?October 20, 2023 | finance.yahoo.comCochlear Limited's (ASX:COH) institutional investors lost 4.5% last week but have benefitted from longer-term gainsOctober 4, 2023 | finance.yahoo.comInvestors in Cochlear (ASX:COH) have seen notable returns of 41% over the past five yearsSee More Headlines Receive COH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/19/2019Ex-Dividend for 4/14 Dividend3/20/2024Dividend Payable4/14/2024Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:COH CUSIPN/A CIKN/A Webwww.cochlear.com Phone+61-2-94286555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$5.33 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth3.87Net Income$350.40 million Net Margins16.30% Pretax MarginN/A Return on Equity20.04% Return on Assets11.80% Debt Debt-to-Equity Ratio11.60 Current Ratio2.57 Quick Ratio1.93 Sales & Book Value Annual Sales$2.15 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow123.45 Book ValueA$27.17 per share Price / BookN/AMiscellaneous Outstanding Shares65,490,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.46 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 57)MBA, CEO, MD, President & Executive Director Comp: $4.78MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 59)Chief Technology Officer Comp: $2.04MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVice President of Investor RelationsRob McGroryGroup General CounselMs. Jennifer StevensonVP of Corporate Communications & BrandMr. Dean PhizackleaSenior Vice President of Global Strategic MarketingMs. Jennifer HornerySenior Vice President of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Senior Vice President of Global Supply ChainMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersDig HowittSold 279 sharesTotal: $60,621.12 ($217.28/share)Michael del PradoBought 117 shares on 11/14/2023Total: $19,798.04 ($169.21/share)Karen PenroseBought 138 shares on 10/18/2023Total: $34,885.99 ($252.80/share)Dig HowittSold 3,622 sharesTotal: $936,431.88 ($258.54/share)Karen PenroseBought 130 shares on 9/5/2023Total: $34,805.94 ($267.74/share) COH Stock Analysis - Frequently Asked Questions How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) issued its quarterly earnings data on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 20.04% and a net margin of 16.30%. How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear declared a Interim dividend on Monday, March 18th. Stockholders of record on Sunday, April 14th will be paid a dividend of 2.00 per share on Sunday, April 14th. This represents a dividend yield of 0.6%. The ex-dividend date is Wednesday, March 20th. This is a positive change from the stock's previous Interim dividend of A$1.55. Read our dividend analysis for COH. Is Cochlear a good dividend stock? Cochlear (ASX:COH) pays an annual dividend of A$4.00 per share and currently has a dividend yield of 1.19%. The dividend payout ratio is 75.05%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for COH. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto Group (RIO), Altium (ALU), Abbott Laboratories (ABT), Afterpay (APT), Appen (APX), Cross Timbers Royalty Trust (CRT) and Janus Henderson Group (HGG). This page (ASX:COH) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingElon Musk’s Controversial New Project: “Apollo”InvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm PressNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.